MICROFISH: how do anthropogenic microplastics and pharmaceutical micropollutants interact and interfere with the marine biosphere
Descrição
MOTIVATION
The oceans are estimated to contain 95% of earth’s biodiversity, ranging from fish (fundamental food and economic sources and models in biomedical and pollution risk assessment research) to a wide range of microorganisms that sustain the planets cycles, food chains and contribute to regulate climate and animals and human health.
Their conservation and sustainable use will be only possible after understanding their biodiversity and on how are natural marine organisms and microbial communities affected by the exponential accumulation of plastics and associated anthropogenic micropollutants.
Worldwide, more than 80% of domestic and industrial effluents enter the oceans raw, accumulating pollutants such as endocrine-disrupting chemicals (EDCs) in marine ecosystems, and even in countries with good sanitation systems diverse pollutants, including pharmaceutical compounds (PhCs), are not completely removed by current wastewater treatment plants (WWTP) treatments.
OBJECTIVES AND TASKS
Research project MicroFish builds on the expertise of its team and collaborating companies and on the previous MicroWaste project to:
1) Screen for microplastics, micropollutants and microbes across seasons and environments, using real-life models WWTPs receiving domestic/hospital sewage and natural fish, waters and extensive aquaculture units at the Ria Formosa and Castro Marim protected areas in the Algarve region, using analytical chemistry and metagenomics.
2) Test if and how microplastics and selected PhCs can associate and determine their persistence or metabolization in sewage, fish and marine environments.
3) Evaluate the biological impacts of exposure to selected plastics and PhCs in the physiology of fish, other marine organisms and their natural microbes, using metagenomics and biochemical / molecular analyses
4) Engage and educate high-school students in project samplings, preparation of tools and divulgation materials as a step to increase ocean literacy, environmental awareness and protection.
TEAM:
The project joins researchers, companies and schools to study the dissemination and impact of marine micro-waste in fish physiology and the equilibria with their microbes, contribute to improve WWTP efficiencies and monitor environmental water quality, while encouraging greater literacy, awareness and environmental protection in civil society.
PARTNERS:
Águas do Algarve SA
Empresa Portuguesa Das Aguas Livres SA (SA) / Grupo Águas de Portugal
AtlantikFish
ADM-Biopolis
Escola Secundária de Loulé (profissional courses, Robotics club and Ciencia Viva club)
Agrupamento de Escolas Tomás Cabreira (profissional courses, Clube Pr’Oceano e Ciencia Viva club)
SPONSORS:
Link: https://www.fam.foundation
European Research Infrastructure for Marine Bioprospecting
Descrição
O principal objetivo do consórcio EUREMAP é otimizar a informação sobre bioprospecção marinha na Europa, para permitir investigação de excelência tanto no meio académico como para a indústria. O projeto ambiciona aproveitar os pontos fortes disponíveis nas infraestruturas de investigação europeias e alinhar as capacidades e os recursos do domínio multidisciplinar da bioprospecção marinha. Assim, para aumentar a competitividade dos produtos naturais marinhos na descoberta de fármacos e reforçar a bioeconomia azul na Europa, iremos criar uma nova linha de investigação que alinhe e integre as capacidades técnicas existentes e as competências multidisciplinares das três infraestruturas de investigação europeias - EU-OPENSCREEN (EU-OS), EMBRC e ELIXIR - no domínio da descoberta de produtos naturais marinhos. O EUREMAP desenvolverá um serviço integrado transversal às três infraestruturas de investigação num domínio prioritário europeu - a economia azul. A informação sobre bioprospecção marinha será uma parte importante da estratégia europeia de crescimento azul para estimular o crescimento económico através de inovações em biotecnologia marinha. O potencial de inovação e de criação de valor no sector da biotecnologia azul é elevado e o sector caracteriza-se por ser multidisciplinar, rico em conhecimentos e baseado em tecnologia. Construir uma nova plataforma europeia transnacional de serviços de infraestruturas de investigação para apoiar a competitividade de uma comunidade académica e industrial em todos os aspectos deste domínio multidisciplinar.